N-[4-[4-butyl-6-(5-methyl-1H-pyrazol-4-yl)-3-pyridinyl]-5-ethenyl-1H-pyrazol-3-yl]-N',N'-dimethylethane-1,2-diamine;1-(cyclohexen-1-yl)-N-[3-(4-methylpiperazin-1-yl)-1H-indazol-5-yl]-1-(5-methyl-1H-pyrazol-4-yl)methanimine;2-[methyl-[7-(5-methyl-1H-pyrazol-4-yl)-3a,8,9,10,11,11c-hexahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]amino]ethanol;9-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8-propyl-3a,6,7,9b-tetrahydro-3H-pyrazolo[4,3-f]quinolin-1-amine
C84H110N26O — CID 163981419
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-[4-butyl-6-(5-methyl-1H-pyrazol-4-yl)-3-pyridinyl]-5-ethenyl-1H-pyrazol-3-yl]-N',N'-dimethylethane-1,2-diamine;1-(cyclohexen-1-yl)-N-[3-(4-methylpiperazin-1-yl)-1H-indazol-5-yl]-1-(5-methyl-1H-pyrazol-4-yl)methanimine;2-[methyl-[7-(5-methyl-1H-pyrazol-4-yl)-3a,8,9,10,11,11c-hexahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]amino]ethanol;9-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8-propyl-3a,6,7,9b-tetrahydro-3H-pyrazolo[4,3-f]quinolin-1-amine
N-[4-[4-butyl-6-(5-methyl-1H-pyrazol-4-yl)-3-pyridinyl]-5-ethenyl-1H-pyrazol-3-yl]-N',N'-dimethylethane-1,2-diamine;1-(cyclohexen-1-yl)-N-[3-(4-methylpiperazin-1-yl)-1H-indazol-5-yl]-1-(5-methyl-1H-pyrazol-4-yl)methanimine;2-[methyl-[7-(5-methyl-1H-pyrazol-4-yl)-3a,8,9,10,11,11c-hexahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]amino]ethanol;9-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8-propyl-3a,6,7,9b-tetrahydro-3H-pyrazolo[4,3-f]quinolin-1-amine (PubChem CID 163981419) has the molecular formula C84H110N26O and a molecular weight of 1499.98 g/mol. Its IUPAC name is N-[4-[4-butyl-6-(5-methyl-1H-pyrazol-4-yl)-3-pyridinyl]-5-ethenyl-1H-pyrazol-3-yl]-N',N'-dimethylethane-1,2-diamine;1-(cyclohexen-1-yl)-N-[3-(4-methylpiperazin-1-yl)-1H-indazol-5-yl]-1-(5-methyl-1H-pyrazol-4-yl)methanimine;2-[methyl-[7-(5-methyl-1H-pyrazol-4-yl)-3a,8,9,10,11,11c-hexahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]amino]ethanol;9-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8-propyl-3a,6,7,9b-tetrahydro-3H-pyrazolo[4,3-f]quinolin-1-amine.
Molecular Properties
| Compound Name | N-[4-[4-butyl-6-(5-methyl-1H-pyrazol-4-yl)-3-pyridinyl]-5-ethenyl-1H-pyrazol-3-yl]-N',N'-dimethylethane-1,2-diamine;1-(cyclohexen-1-yl)-N-[3-(4-methylpiperazin-1-yl)-1H-indazol-5-yl]-1-(5-methyl-1H-pyrazol-4-yl)methanimine;2-[methyl-[7-(5-methyl-1H-pyrazol-4-yl)-3a,8,9,10,11,11c-hexahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]amino]ethanol;9-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8-propyl-3a,6,7,9b-tetrahydro-3H-pyrazolo[4,3-f]quinolin-1-amine |
|---|---|
| PubChem CID | 163981419 |
| Molecular Formula | C84H110N26O |
| Molecular Weight | 1499.98 g/mol |
| Exact Mass | 1498.94 |
| IUPAC Name | N-[4-[4-butyl-6-(5-methyl-1H-pyrazol-4-yl)-3-pyridinyl]-5-ethenyl-1H-pyrazol-3-yl]-N',N'-dimethylethane-1,2-diamine;1-(cyclohexen-1-yl)-N-[3-(4-methylpiperazin-1-yl)-1H-indazol-5-yl]-1-(5-methyl-1H-pyrazol-4-yl)methanimine;2-[methyl-[7-(5-methyl-1H-pyrazol-4-yl)-3a,8,9,10,11,11c-hexahydro-3H-pyrazolo[4,3-a]phenanthridin-1-yl]amino]ethanol;9-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8-propyl-3a,6,7,9b-tetrahydro-3H-pyrazolo[4,3-f]quinolin-1-amine |
| SMILES | C=Cc1[nH]nc(NCCN(C)C)c1-c1cnc(-c2cn[nH]c2C)cc1CCCC.CCCC1=C(C)C2=C(C=CC3NN=C(N)C23)NC1c1cn[nH]c1C.Cc1[nH]ncc1-c1nc2c(c3c1CCCC3)C1C(N(C)CCO)=NNC1C=C2.Cc1[nH]ncc1/C(=N/c1ccc2[nH]nc(N3CCN(C)CC3)c2c1)C1=CCCCC1 |
| InChI | InChI=1S/C23H29N7.C22H31N7.C21H26N6O.C18H24N6/c1-16-20(15-24-26-16)22(17-6-4-3-5-7-17)25-18-8-9-21-19(14-18)23(28-27-21)30-12-10-29(2)11-13-30;1-6-8-9-16-12-20(17-14-25-26-15(17)3)24-13-18(16)21-19(7-2)27-28-22(21)23-10-11-29(4)5;1-12-15(11-22-24-12)20-14-6-4-3-5-13(14)18-16(23-20)7-8-17-19(18)21(26-25-17)27(2)9-10-28;1-4-5-11-9(2)15-13(6-7-14-16(15)18(19)24-23-14)21-17(11)12-8-20-22-10(12)3/h6,8-9,14-15H,3-5,7,10-13H2,1-2H3,(H,24,26)(H,27,28);7,12-14H,2,6,8-11H2,1,3-5H3,(H,25,26)(H2,23,27,28);7-8,11,17,19,25,28H,3-6,9-10H2,1-2H3,(H,22,24);6-8,14,16-17,21,23H,4-5H2,1-3H3,(H2,19,24)(H,20,22)/b25-22+;;; |
| InChIKey | SYSKMXXKQFEWMO-ICVVXADVSA-N |
| XLogP | 12.24 |
| TPSA | 342.27 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 21 |
| Rotatable Bonds | 20 |
| Heavy Atoms | 111 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1499.98 |
| LogP ≤ 5 | 12.24 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 21 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163981419 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.